Syngene International Q1 FY27: posts net loss of ₹9 crore, revenue down 16%
Syngene International (NSE: SYNGENE) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹736 crore (−15.8% year on year), a net loss of ₹9 crore (−110.4%), earnings per share of ₹-0.22. The company is valued at about ₹14,782 crore.
What happened
Syngene International (NSE: SYNGENE) informed the stock exchanges on 27 October 2026 at 07:35 PM that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹736 crore (−15.8% year on year), a net loss of ₹9 crore (−110.4%), earnings per share of ₹-0.22.
Company snapshot
Syngene International is a small-cap company in the Healthcare sector, with a market value of about ₹14,782 crore.
The stock last traded at ₹366.2, against a 52-week range of ₹344.5–₹679 (46.1% below the high).
Before this filing the shares had moved −3.9% over the month and −11.4% over three months. Average daily turnover over the last 20 sessions was about ₹25.15 crore.
Promoters held 52.59% at the end of Q1 FY27, down 0.09% points from the previous quarter. Foreign institutions owned 11.82% and domestic institutions 28.02%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 875 | 86.7 | 2.16 |
| Q2 FY26 | 911 | 67.1 | 1.67 |
| Q3 FY26 | 917 | 15 | 0.37 |
| Q4 FY26 | 1,037 | 147.9 | 3.68 |
| Q1 FY27 | 736 | -9 | -0.22 |
What history shows
This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +0.9% on average the next day and +1.9% over five days; 55% of them rose the next day.
Market-wide, 9,800 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.